vanilmandelic acid has been researched along with Chronic Kidney Diseases in 1 studies
Vanilmandelic Acid: A 3-O-methyl ether of 3,4-dihydroxymandelic acid. It is an end-stage metabolite of CATECHOLAMINES; EPINEPHRINE; and NOREPINEPHRINE.
vanillylmandelic acid : An aromatic ether that is the 3-O-methyl ether of 3,4-dihydroxymandelic acid.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pawlak, D | 1 |
| Domaniewski, T | 1 |
| Znorko, B | 1 |
| Oksztulska-Kolanek, E | 1 |
| Lipowicz, P | 1 |
| Doroszko, M | 1 |
| Karbowska, M | 1 |
| Pawlak, K | 1 |
1 other study available for vanilmandelic acid and Chronic Kidney Diseases
| Article | Year |
|---|---|
The impact of peripheral serotonin on leptin-brain serotonin axis, bone metabolism and strength in growing rats with experimental chronic kidney disease.
Topics: Alkaline Phosphatase; Animals; Biomarkers; Biomechanical Phenomena; Bone and Bones; Bone Remodeling; | 2017 |